Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...
The agent, first approved in December for biweekly subcutaneous injection for EGFR-mutated NSCLC, showed similar efficacy and safety when administered monthly.
More recently established treatments for RVO have taken a giant leap forward from laser photocoagulation since intravitreally ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Prompt injection attacks can manipulate AI behavior in ways that traditional cybersecurity ...
Under its former childhood vaccine schedule, the U.S. Centers for Disease Control and Prevention recommended that kids get 12 different vaccines protecting against 16 diseases before age 10. It didn’t ...
GLP-1 (glucagon-like peptide-1 receptor agonists) like Ozempic and Wegovy continue to make headlines as more research points to the benefits of taking these medications. Traditionally, patients ...
Port fuel injection (PFI) was a major milestone in the early '80s. The integration of PFI rapidly changed the way fuel was delivered by increasing fuel economy and improving engine performance. Even ...
Lerodalcibep-liga, a once-monthly PCSK9 inhibitor, significantly reduces LDL-C in hypercholesterolemia, including HeFH, with FDA approval for subcutaneous use. The LIBerate Program showed sustained ...
A Boxed Warning explaining the risk of medication errors involving inadvertent neuraxial administration will be added to the labeling. The Food and Drug Administration (FDA) has issued an updated ...
The body’s defenses may be mildly lowered for about 1 to 4 weeks after a single steroid shot into a joint or near your spine. In some people, particularly with higher doses, this effect may last up to ...
July 14 (Reuters) - The World Health Organization on Monday recommended Gilead's (GILD.O), opens new tab lenacapavir, a twice-yearly injection, as a tool to prevent HIV infection. The recommendation, ...
A once-a-week Parkinson’s injection could replace multiple daily pills, thanks to a new slow-release formulation developed by researchers. It promises easier treatment, fewer missed doses, and better ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results